Luoxin Pharmaceuticals Group Stock Co Ltd Strategic Asset Allocation Index
Luoxin Pharmaceuticals Group Stock Co Ltd strategic asset allocation index. Luoxin Pharmaceuticals Group Stock Co Ltd (002793) has a Strategic Asset Allocation Index of 55.9% as of September 2023. Strategic assets (PP&E of CN¥1.71 Billion plus long-term investments of CN¥-) total CN¥1.71 Billion, measured against net assets of CN¥3.06 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Luoxin Pharmaceuticals Group Stock Co Lt to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Luoxin Pharmaceuticals Group Stock Co Ltd (2011–2022)
Strategic asset allocation index of Luoxin Pharmaceuticals Group Stock Co Ltd from 2011 to 2022. This chart shows how Luoxin Pharmaceuticals Group Stock Co Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of September 2023, the index stands at 55.9%, representing strategic assets of CN¥1.71 Billion against net assets of CN¥3.06 Billion CNY. Check 002793 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Luoxin Pharmaceuticals Group Stock Co Ltd Strategic Asset Allocation Index by Year (2011–2022)
Luoxin Pharmaceuticals Group Stock Co Ltd strategic asset allocation index by year from 2011 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Luoxin Pharmaceuticals Group Stock Co Ltd from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 002793 market cap overview.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 53.8% | CN¥1.78 Billion | CN¥1.78 Billion | CN¥- | CN¥3.31 Billion | ▲ +10.0 pp |
| 2021 | 43.7% | CN¥2.07 Billion | CN¥2.07 Billion | CN¥- | CN¥4.74 Billion | ▼ -0.4 pp |
| 2020 | 44.2% | CN¥1.92 Billion | CN¥1.92 Billion | CN¥- | CN¥4.35 Billion | ▼ -0.1 pp |
| 2019 | 44.3% | CN¥1.75 Billion | CN¥1.75 Billion | CN¥- | CN¥3.96 Billion | ▼ -119.2 pp |
| 2018 | 163.5% | CN¥1.49 Billion | CN¥1.49 Billion | CN¥- | CN¥909.89 Million | ▲ +133.5 pp |
| 2017 | 30.0% | CN¥226.15 Million | CN¥226.15 Million | CN¥- | CN¥754.19 Million | ▼ -123.6 pp |
| 2016 | 153.6% | CN¥1.07 Billion | CN¥983.34 Million | CN¥89.33 Million | CN¥698.33 Million | ▼ -121.1 pp |
| 2015 | 274.7% | CN¥932.72 Million | CN¥862.43 Million | CN¥70.29 Million | CN¥339.50 Million | ▲ +19.5 pp |
| 2014 | 255.2% | CN¥805.18 Million | CN¥764.18 Million | CN¥41.00 Million | CN¥315.46 Million | ▲ +0.6 pp |
| 2013 | 254.6% | CN¥640.32 Million | CN¥599.32 Million | CN¥41.00 Million | CN¥251.50 Million | ▲ +222.8 pp |
| 2012 | 31.8% | CN¥65.30 Million | CN¥65.30 Million | CN¥- | CN¥205.54 Million | ▼ -8.0 pp |
| 2011 | 39.7% | CN¥60.36 Million | CN¥60.36 Million | CN¥- | CN¥151.87 Million | — |